0.025
0.03 (0.00%)
| 收盘价格 | 0.025 |
| 成交量 | 6,364 |
| 平均成交量 (3个月) | 544 |
| 市值 | 526 |
| 52周波幅 | |
| 利润日期 | 4 Jun 2025 - 6 Jun 2025 |
| 营业毛利率 | -102.77% |
| 营业利益率 (TTM) | -105.91% |
| 稀释每股收益 (EPS TTM) | -12.63 |
| 季度收入增长率 (YOY) | 5.40% |
| 总债务/股东权益 (D/E MRQ) | 8.62% |
| 流动比率 (MRQ) | 2.40 |
| 营业现金流 (OCF TTM) | -11.51 M |
| 杠杆自由现金流 (LFCF TTM) | -2.25 M |
| 资产报酬率 (ROA TTM) | -23.39% |
| 股东权益报酬率 (ROE TTM) | -61.27% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看涨 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看涨 | 混合的 | |
| 股票 | Clever Leaves Holdings Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.50 |
|
Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments namelyThe Cannabinoid operating segment which is comprised of the company’s cultivation, extraction, and commercialization of cannabinoid products; and Non-Cannabinoid operating segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 21.79% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合